Transdermal Drug Delivery Resources
-
Solubility With Lipid-Based Technologies For Oral & Injectable Formulations
11/7/2022
Innovative approaches in developing formulations can help to improve a drug's safety and efficacy. Explore the decision for selecting the best-suited technology for formulating a complex molecule.
-
Formulation Development From Preclinical To First-In-Human
1/24/2022
A compound with poor biopharmaceutical properties or improper formulation design could lead to a delay in the project or even program termination.
-
Microphysiological Systems: Closing The Gap Between Models And Medicine
9/2/2025
Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.
-
10 Ways To Align Your Medical Device With Human Factors Industry Best Practices
3/1/2024
Discover how patient-centric design principles can improve the development of medical devices. By focusing on user needs and behaviors, manufacturers can ensure that products align with expectations.
-
Drug Formulation Development: Quick Reference Guide
7/11/2022
This guide shares the steps involved in formulation development, considerations during formulation, and how partnering with an experienced CDMO can lead to a successful commercial product.
-
Contract Design And Development Vs. In-House: How To Find The Best Fit
3/21/2024
Explore the rationale behind opting for a contract development organization (CDO) to fulfill organizational requirements and underscore vital considerations for evaluating CDOs to ensure alignment with your project objectives.
-
Combination Products: Market Trends And Regulatory Considerations
1/17/2024
Combination products provide significant avenues for increasing patient adherence and overall efficacy. This collection outlines the opportunity and identifies strategies for gaining regulatory approval.
-
Is Your Combination Product Drug-Led Or Device-Led?
11/30/2022
The $118 billion combination-product market is projected to increase at a CAGR of 8.8%. This article answers the question: “Is this actually a combination product? What do we need to do if it is?”
-
3D Screen Printing: Enabling A New Generation Of Complex Formulations
3/17/2025
Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.
-
Semi-Solid And Semi-Liquid Dosage Forms: What To Know
3/7/2023
Interest in semi-solid dose (SSD) forms has been on the rise. Learn more about the advantages of formulating medications into SSD forms as well as the challenges to consider.